Finn Partners has upped Kristie Kuhl to managing partner & global health practice leader, succeeding Gil Bashe, who remains chair of the $35M unit.
She joined Finn in 2015 as US pharma & New York health head after executive VP stints at Cohn & Wolfe and Makovsky, handling marketing, regulatory law, patient advocacy and reimbursement issues.
“Kristie joined the health practice at its earliest moments and is an amazing voice for our talent, agency values and societal need,” Bashe told O’Dwyer’s.
Noting that health is one of Finn’s largest practices, Bashe said Kuhl’s promotion is a signal that "we are looking to grow careers, impact clients and create opportunities throughout the agency.”
Kuhl, who calls Finn Health a “purpose-driven organization,” said her job as practice leader “is to ensure that people have the information and resources they need to serve the most innovative health companies so that we have a positive impact on people's health.”
As chair, Bashe will continue to focus on acquisitions, strategy, client relationships and ally partnerships.
Finn’s health group has about 175 staffers.